Why it matters: ECRI called AI in healthcare the #1 patient safety risk of 2026. Here’s where it is helping, where it is harming, and what to watch next.
Why it matters: Growing uses of AI in diagnostics span radiology, pathology, retina, cardiology, and lab medicine, with 1,451 FDA cleared AI devices by late 2025.
Why it matters: See how AI is reshaping diagnostics, drug discovery, and patient care in 2026. Real case studies, ROI data, and regulatory shifts to know.
Why it matters: How Hospitals Use Algorithms to Prioritize Vaccine Distribution: risk scoring, equity weighting, Stanford controversy lessons, and best practice.